Trademark: 79139511
Status Date
Tuesday, January 17, 2023
Registration Number
4709950
Registration Date
Tuesday, March 31, 2015
Filing Date
Wednesday, January 16, 2013
Published for Opposition
Tuesday, January 13, 2015
Cancellation Date
Tuesday, January 17, 2023
41 Arranging and conducting educational seminars, conferences, symposiums, training workshops and courses; educational and training services in the form of educational seminars, conferences, symposia, education workshops and courses in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; educational and training services in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention provided electronically, on-line, via cable or Internet or other electronic media; arranging and conducting of on-line educational forums, in the form of educational seminars, conferences, symposia, education workshops and courses; on-line training programs in the field of pharmaceutical research and development; providing non-downloadable on-line publications, namely, of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; on-line publication of medical data and analysis reports designed to provide patients and clients customized information, namely, medical dose, diagnosis, therapeutic issues and medical administration
9 Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of * clinical or medical diagnostic* research and development, * clinical or medical diagnostic * science, clinical tests,* clinical or medical * diagnostics, medicine, pharmaceuticals, * medical * disorders, * medical * diseases, *clinical or medical * treatment and prevention; [ data processing equipment and computers; computer hardware and software for information and information management for use of a web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; ] application software for mobile devices, namely, applications with customized information regarding medicine dosage, medical diagnosis, therapy and medical information regarding central nervous system diseases and disorders; [ downloadable electronic publications in the nature of manuals in the field of central nervous system diseases and disorders ]
5 Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcohol dependency; vaccines; medicinal preparations for the treatment of central nervous system diseases and disorders and diagnostic preparations for medical purposes
16 [ Printed instructional, educational and teaching materials in the field of research regarding depression; ] publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development of central nervous system diseases and disorders and pharmaceuticals for the treatment and prevention of depression, medical science, clinical tests, diagnostics of central nervous system diseases and disorders, medicine, pharmaceuticals for the treatment of central nervous system diseases and disorders and the treatment and prevention of depression and central nervous system disorders and diseases
35 Retail and wholesale store services featuring pharmaceuticals; promotion and advertising services in the field of research and development, science, clinical tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; provision of the aforementioned services on-line, via cable or Internet or other electronic media
44 Medical services; medical clinical services; medical treatment services; therapeutic treatment services; healthcare and medical services all related to central nervous system disorders, diseases and pharmaceuticals for the treatment thereof; providing medical and medicinal information in the field of diagnosis, medicine, pharmaceuticals, disorders, diseases, treatments and prevention; medical information services; diagnostic tests all in the field of central nervous system diseases and disorders
10 Medical test kits for the treatment and study of alcohol dependency; medical instruments and apparatus for the treatment and study of alcohol dependency
42 Providing on-line non-downloadable software for pharmaceutical research and development; scientific and technological research in the field of central nervous system disorders, * medical * diseases and the prevention thereof; medical research and tests; clinical research and tests; diagnostic research in the field of alcohol dependency; providing research and development services in the fields of medicine, science and clinical testing
In the statement, page, 1 line 22, after of, " clinical or medical diagnostic " should be inserted. In the statement, page 1, line 21, after development, " clinical or medical " should be inserted. In the statement, page 1, line 22, after tests, " clinical or medical diagnostic " should be inserted. In the statement, page 1, line 23, after maceuticals, " medical " should be inserted. In the statement, page 1, line 23, after disorders, " medical " should be inserted. In the statement, page 1, line 23, after diseases " clinical or medical " should be inserted. In the statement, page 1, lines 23 through 27, after, prevention; " data processing equipment and computers; computer hardware and software for information and information management for use of a web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; " should be deleted. In the statement, page 1, lines 31 through 33, " downloadable electronic publications in the nature of manuals in the field of central nervous system diseases and disorders " should be deleted. In the statement, page 2, lines 4 and 5, " Printed instructional, educational and teaching materials in the field of research regarding depression; " should be deleted. In the statement, page 2, line 46, after disorders, " medical " should be inserted.
Color is not claimed as a feature of the mark.
Aug 6, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Aug 6, 2023
Death Of International Registration
Jan 24, 2023
Limitation From The Ib Examined, No Action Is Needed
Dec 10, 2022
Limitation Of Goods Received From Ib
Sep 26, 2022
Total Invalidation Processed By The Ib
Sep 1, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 1, 2022
Invalidation Processed
Jul 26, 2022
Total Invalidation Of Reg Ext Protection Created
Nov 26, 2021
Cancelled Section 71
Mar 31, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jun 1, 2016
Invalidation Reviewed - No Action Required By Office
May 29, 2016
Partial Invalidation Of Reg Ext Protection Created
Dec 22, 2015
Correction From The Ib Examined, No Action Is Needed
Dec 10, 2015
Limitation From The Ib Examined, No Action Is Needed
Nov 27, 2015
Correction Transaction Received From Ib
Nov 27, 2015
Limitation Of Goods Received From Ib
Oct 2, 2015
Final Decision Transaction Processed By Ib
Sep 29, 2015
Limitation From The Ib Examined And Entered
Sep 29, 2015
Correction Under Section 7 ¿ Processed
Sep 29, 2015
Case Assigned To Post Registration Paralegal
Aug 28, 2015
Limitation Of Goods Received From Ib
Aug 11, 2015
Final Disposition Notice Sent To Ib
Aug 11, 2015
Final Disposition Processed
Jun 30, 2015
Final Disposition Notice Created, To Be Sent To Ib
Mar 31, 2015
Registered-Principal Register
Jan 15, 2015
Notification Processed By Ib
Jan 13, 2015
Official Gazette Publication Confirmation E-Mailed
Jan 13, 2015
Published For Opposition
Dec 24, 2014
Notification Of Possible Opposition Sent To Ib
Dec 24, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 24, 2014
Notification Of Notice Of Publication E-Mailed
Dec 8, 2014
Law Office Publication Review Completed
Dec 8, 2014
Approved For Pub - Principal Register
Dec 8, 2014
Examiner's Amendment Entered
Dec 5, 2014
Notification Of Examiners Amendment E-Mailed
Dec 5, 2014
Examiners Amendment E-Mailed
Dec 5, 2014
Examiners Amendment -Written
Jun 17, 2014
Notification Of Non-Final Action E-Mailed
Jun 17, 2014
Non-Final Action E-Mailed
Jun 17, 2014
Non-Final Action Written
Jun 17, 2014
Previous Allowance Count Withdrawn
Jun 12, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 12, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 25, 2014
Withdrawn From Pub - Og Review Query
Apr 17, 2014
Law Office Publication Review Completed
Apr 17, 2014
Assigned To Lie
Mar 26, 2014
Approved For Pub - Principal Register
Mar 26, 2014
Teas/Email Correspondence Entered
Mar 25, 2014
Correspondence Received In Law Office
Mar 25, 2014
Teas Response To Office Action Received
Jan 6, 2014
Refusal Processed By Ib
Dec 17, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Dec 17, 2013
Refusal Processed By Mpu
Dec 17, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Dec 17, 2013
Application Filing Receipt Mailed
Dec 16, 2013
Non-Final Action Written
Dec 11, 2013
Assigned To Examiner
Dec 11, 2013
New Application Office Supplied Data Entered
Dec 9, 2013
Limitation From Original Application Entered
Dec 6, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
